NASDAQ: GILD - Gilead Sciences

Rentabilité sur six mois: +29.93%
Rendement en dividendes: +3.69%
Secteur: Healthcare

Nouvelles Télégramme
Drugmakers raised prices by 6.6% on average early this year

18 novembre 17:51 Drugmakers raised prices by 6.6% on average early this year

COVID-19 vaccine start-up files for IPO

18 novembre 17:19 COVID-19 vaccine start-up files for IPO

Inside the race for a COVID-19 treatment pill

18 novembre 16:26 Inside the race for a COVID-19 treatment pill

Merck COVID-19 pill success slams Moderna shares, shakes up health care sector

18 novembre 16:25 Merck COVID-19 pill success slams Moderna shares, shakes up health care sector